Alemtuzumab Intravenous and Hematinic with Folic Acid
Determining the interaction of Alemtuzumab Intravenous and Hematinic with Folic Acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: ferrous fumarate / folic acid
Brand name: Ed Cyte F, Hematinic with Folic Acid, Hemocyte-F, Ferrocite F, Nephro-Fer RX, Equi-Cyte F, Ircon-FA, Drysol, Hypercare, Xerac AC
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Hematogen FA Capsules
- Alemtuzumab Intravenous-Hematogen Forte
- Alemtuzumab Intravenous-Hematogen Softgels
- Alemtuzumab Intravenous-Hematron
- Alemtuzumab Intravenous-Hemax
- Alemtuzumab Intravenous-Heme iron polypeptide
- Hematinic with Folic Acid-Alenaze-D
- Hematinic with Folic Acid-Alendronate
- Hematinic with Folic Acid-Alendronate and cholecalciferol
- Hematinic with Folic Acid-Alendronate Effervescent Tablets
- Hematinic with Folic Acid-Alendronate Oral Solution
- Hematinic with Folic Acid-Alendronate Sodium